Categorical data on the response to treatment for mastitis are analyzed by several methods. The most important aspect of these analyses is the emphasis that 'the cow rather than a quarter of the udder is the basic experimental unit. Thus, the untenable assumption of independence among the qU3r-ters of an udder is not required. Given this framework, it is shown by example that many questions of interest can be investigated by weighted regression analysis. In particular, methodological strategies are outlined for 1. assessing the extent of interaction among experimental factors and its implications to model fitting for describing relationships, 2. accounting for pre-treatment scores as a covariable, 3. undertaking multivariate analyses with respect to the four quarters simultaneously.
Introduction
A study of the treatment of mastitis in dairy cows presents many of the same problems encountered in clinical trials of therapies that use human subjects. In this regard, the design and analysis issues that should receive attention can be summarized as follows:
1. Statement of the problem and study objectives.
Specification of what class of animals are eligible
for the study. It is important to be specific about this because it defines the population to which the findings of the study apply.
3. Description of the therapies under study and indications for their modification and for when other supportive measures are permitted. 4 . Specification of criteria for evaluation of the outcome of treatment. This is sometimes called the end point in clinical trials.
5. Specification of sample size and the extent to which it is large enough to detect clinically important differences.
6. Description of the randomization scheme and/or other technical aspects of the research design. This should indicate whether blocking is to be used to control for heterogeneity and whether there are important covariables to be included in the analysis.
7. Description of the methods to be used for data analysis.
The questions on this list require knowledge of physiology, the natural history of the disease, cli.nical practice and statistics for their resolution.
This paper deals mostly with statistical methods for data analysis specifically with respect to the results of a clinical trial for the treatment of mastitis.
The Problem
Heald et ale (2) described a clinical trial to i. optimize the dose of penicillin for the treatment of Streptoc.occus agalactiae at drying-off when the drug e· 3 was used in combination with novobiocin for the treatment of Staphylococcus aureus, and
ii. determine if a combination of penicillin and novobiocin was justified for treatment of both infections at drying off.
Cows from sixteen Southwestern Virginia Holstein dairy farms were used in the study, including both milking parlor and stanchion barn herds. These herds also reflected a range of subjective management scores of poor, fair, good, and excellent, as judged by the technicians who visited the farms on a weekly basis. Cows were assigned sequentially as they were identified, rather than randomly, to one of the following nine treatments:
No treatment (Control)
2. 1x10 5 I. u. Penicillin . . In addition, dairymen sometimes requested that certain cows be treated.
These cows were given one of the eight active (non-control) treatments.
Other specific details concerning the research design for this investigation are given in (2) .
The infections present at the beginning and at the end of treatment were identified and constituted the basic data for analysis. Although many different organisms were potentially involved, they have been pooled here in order to simplify the discussion of alternative statistical methods. Thus, the presence or absence of any infection at the beginning and end of the 4 study for each of the four quarters of the cow's udder are the variables to be used for treatment evaluation.
The Method
As indicated by Miller (5) , the infection state variables for the four quarters of the cows udder are generally not independent. Thus, the usual types of contingency table analyses cannot be validly applied to the raw data for the respective quarters. However, certain related methods which are both more powerful and more comprehensive can be adapted to this situation without great changes in concept because they provide a framework which permits the quarter data to be appropriately linked to the corresponding cows.
Consider each quarter of a cow's udder as being infected or not, before and after treatment. This combination of conditions can be represented in a 2x2 where I denotes infected and I, not infected; n . . denotes the probability of J i J 2 the (jl' j2)-th state combination for a given quarter and experimental condition; and the {TI j j } sum to 1.
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Tables can be constructed for each quarter. Similarly, the marginal Average probabilities for each herd are shown in Table 2 . These quantities are more difficult to interpret because of their variability and the small sample sizes. However, to get an idea of whether there are herd effects, the herd management scores are considered. These data are also shown in Table 2 . From this point of view, it can be seen that both the average probability of being infected at the beginning of the study period and at th~end depend somewhat on the quality of management. In this regard, there seems tob e a trend toward smaller probabilities of infection as the herd management score varies from poor to excellent, although there is substantial overlap among them; e.g., poor and fair management scores have similar state distributions, as do good and excellent.
Before proceeding to more detailed analyses, a check of the comparability of the cows assigned to different treatments is worth making, particularly since they were not randomly assigned. One way of examining this issuẽ is to combine the II and II classes within treatments and then to test for homogeneity across treatments, i.e., to determine whether the average probability of being infected at the beginning of the study is the same for each treatment. These quantities are shown in Table 3 and can be seen to be reasonably homogeneous. A formal test statistic which supports this interpretation is given later. Another check of interest is to examine the difference between the average probabilities of being infected before treatment Table 4 .a.
The remainder of the analysis in this section will be directed at the .~ The parameters for this model correspond respectively to the following: predicted value for no treatment for cows with poor or fair management, (negative) increment effect for good or excellent management, eight separate (negative) increments for the successive active treatments as arranged in table 4.3.
Estimate + s.e.
The parameters for this model correspond respectively to the following: predicted value for no treatment without regard to management, and common (negative) increment for any of the eight active treatments. where V is the estimated covariance matrix for the vector of estimated pro--£ portions £. For more complete computational details, see (1) , (3), and (4). 14 The effects of treatment and management on the post-treatment means will be examined by weighted least squares regression. A main effect model X containing treatment and management effects is used to test for treat--m ent differences after adjustment for the effects of herd management score.
The specific structure of this model together with estimated parameters is shown in Table 4 .b. Since its goodness of fit test statistic in Table 4 .c is non-significant (a=.25), further consideration of its implications is warranted.
The other test statistics in the weighted analysis of variance (WANOVA) Table 4 .c show that differences among treatments are significant (a=.05) , and the main effect due to herd management score is non-significant (a=.25).
Also, the differences among the active (non-control) treatments are clearly non-significant (a=.25). Thus, the main effect model X is reduced to the -f inal model~FM which has only two parameters; namely, a baseline overall estimated mean of (1.88 + .21) infected quarters for the control treatment and a common estimated effect of (-1.13 + .22) infected quarters for the active treatments.
For the sake of completeness, it is of interest to consider the treatment main effect model~~shown in Table 5 as an alternative to~FM. However, the goodness of fit test statistic for this model is significant (a=.05) and thus implies that its use is not appropriate. In addition, the difference between the goodness of fit test statistic for~TME and the goodness of fit test statistic for the preliminary main effect model~.
corresponds tõ The parameters for this model correspond respectively to the following: predicted value for no treatment for cows with poor or fair management, (negative) increment for good or excellent management, (negative) increments for 100,000 units, 200,000 units, and 400,000 units of Penicillin, and (negative) increments for 400 and 600 mg of Novobiocin.
The 16 the effects of the two drugs. However, in view of the other results given for~ME and subsequently eFM' its interpretation is straightforward.
lowest dosage under study for either drug considered separately gives the maximal reduction in the number of infected quarters, and higher dosages or drug combinations provide no further reduction.
Bivariate analysis of pre-treatment and post-treatment total numbers of infected quarters
Let~ii denote the total number of infected quarters at the h-th time for the i-th cow in the i-th treatment group where h = 1, 2, for (pre, post); i = 1, 2, ... There are s = 9 sub-populations corresponding to the respective treatments. Thus, the bivariate analysis of pre-treatment and post-treatment total numbers of infected quarters can be formulated as matrix operations on the underlying (9x25) contingency table displayed in Table 6 Otherwise, it should be recognized that although the~matrix linear transformation of £ is a straightforward way to define the functions {~i}' they are most readily computed as raw data mean scores as described in (3) and (4).
The variation among the estimated pre-treatment and post-treatment mean numbers of infect~d quarters will be investigated by weighted least squares. Initially, the preliminary cell mean identity model~M = !18 ' is used to test hypotheses about the treatment differences for the pre and post mean scores. These tests are given in Table 7 Table 7 .cS ince the residual goodness of fit test statistic for this model is clearly non-significant (a=.2S), further consideration of its implications is warranted. As with~M ' these results indicate that differences among The parameters for this model correspond respectively The parameters for this model correspond tQ the following: predicted value for common preto the following: predicted value for treatment status of all cows, predicted value for common pre-treatment status of all cows post-treatment status of cows with no treatment (conand common (negative) increment for the trol) , eight separate (negative) increments for the post-treatment status of cows on any of successive active treatments as arranged in Thus, this application involves one response variable with 9 outcome levels and 9 sub-populations corresponding to the respective treatments. The resuIting 9x9 contingency table is displayed in Table 8 .
The estimated mean pre-treatment versus post-treatment difference scores for the 9 treatment groups can be computed from the contingency table   in Table 8 Table 8 . These same quantities could also have been computed from the con- tingency table in Table 6 The parameter for this model corresponds to the common value for the extent of improvement between pre-treatlllcnt and posttreatment for cows on any of the eight active treatments. an (8x8) are given in Table 9 . pertaining to quarter differences within treatments and treatment differences within quarters. Corresponding test statistics are given in Table 9 .
These results indicate that significant (a=.05) treatment differences are most apparent for quarter 2 and that significant (a=.05) quarter differences are most apparent for treatment 6 and treatment 7 (or more generally Novobiocin = 400 mg). Otherwise, the quarter differences for the control treatment are clearly non-significant. In view of the results in the previous section for the overall difference score (summed over quarters), test statistics are also provided for the comparison of the active treatments within each quarter. Although these are individually all non-significant (a=.25), the interpretation of their simultaneous test statistic is not so straightforward since its significance is borderline (.OS < a < .10). Thus, it becomes of interest to investigate the types of models which can be fitted to the quarter difference scores for both the case where this result is regarded as nonsignificant as well as the case where it is regarded as significant. In this way, the nature of any conflict between them can be used as a basis for judging which approach is most sensible in terms of the conclusions which it implies.
If the simultaneous test statistic for within quarter equality of active (non-control) treatments is interpreted to be non-significant, then the same final model which was found to be appropriate for the overall difference scores can be jointly applied to the separate quarters. This joint Table 10 .a. On examining these quantities more closely, it can be seen that the estimated improvement is greater for the two quarters on the left 28 The parameters for this model correspond to the common value for the active (non-control) treatments for the improvement of Q2 and Q4 and a combined side and front-rear increment (decrement) for Q1(Q3).
The parameters for this model correspond to the common value for the extent of improvement between pretreatment and post treatment for the respective four quarters for cows on any of the active (non-control) treatments.
- Table 10 .b, these quarter location differences are both significant (a=.OI); and the interaction between them is non-significant (a=.25). On the basis of these conclusions and the fact that side differences and front-rear differences are approximately the same the model X is reduced to the final model X whose parameters cor- Thus, it can be seen that for each of the active (non-control) treatments, the most improvement occurred for the left front quarter and the least for the right rear. Finally, an overall estimate of improvement can be obtained from this analysis by adding the separate estimates for the four quarters together.
For the model X ,this approach leads to an overall estimate of (1.02 + .09) -m -for the common net reduction of infected quarters for the cows which received any of the active treatments. In this sense, it essentially yields the same conclusion concerning treatment differences as the simpler analyses given in previous sections for the total numbers of infected quarters at pre-treatment and post-treatment, but at the same time provides additional interesting: information about the differences in improvement for the four separate quarters.
Alternatively, if the simultaneous test statistic for within quarter equality of active treatments is interpreted as significant, a somewhat dif-ferent analytical strategy is needed. More specifically, it becomes necessary to identify which of the four quarters is responsible for the significance of this test statistic. In this regard, quarter 2 (left rear) appears to be a strong possibility because it has a somewhat wider range of difference scores for the active treatments than the other three quarters. Moreover, treatment 9 (Novobiocin=600 m~seems to be somewhat less effective for this quarter than the other active treatments which again seem to be relatively similar with respect to their respective estimates for extent of improvement. Putting is larger, and less non-significant (0=.10). However, X is more difficult -JM to interpret than X because there does not seem to be any sensible reason -JM why treatment 9 would have no effect on quarter 2 and an effect equal to the other active treatments on the other three quarters and why it would have less effect on quarter 2 than treatment 5 which is its smaller dosage counterpart. In other words, the relatively small estimated value for improvement 31 of quarter 2 for cows given treatment 9 would seem to be either a consequence of data collection or transcription errors or simply a relatively unexpected random event. Since the latter interpretation is considered more reasonable, the analysis based on X and X FM is judged to be more preferable than that -JM -based on~JM.
Other types of analyses 
